Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis. (nejm.org)

Authors: Torkildsen O … Myhr KM Journal: New England Journal of Medicine Published: 2026-07-02 DOI: https://doi.org/10.1056/NEJMoa2600993